BioNTech/ Genmab post early data for lung cancer therapy (NASDAQ:BNTX)
koto_feja BioNTech (NASDAQ:BNTX) and Genmab (GMAB) introduced Saturday that their investigational bispecific antibody acasunlimab improved survival charges amongst lung most ...
Tag: cancer
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Skynesher | E+ | Getty PicturesMassive pharma is betting billions on an up-and-coming class of most cancers remedies that some ...
Fitness influencer gets candid out about having stage 4 colon cancer
Maria Kang has by no means been one for retaining quiet. The Sacramento-based health influencer and mom of three has ...
J&J wins trial over Florida woman who claimed its baby powder caused her cancer By Reuters
By Dietrich Knauth NEW YORK (Reuters) - A Florida jury on Thursday concluded that Johnson & Johnson (NYSE:)'s child powder ...
Driving Advancements in TCR-T Cell Therapy for Cancer – TradersPro
Tscan Therapeutics Inc (TCRX) is a biotechnology firm targeted on the event of T cell receptor (TCR)-engineered T cell ...
BeiGene gets FDA approval for esophageal cancer drug Tevimbra (NASDAQ:BGNE)
Bet_Noire BeiGene (NASDAQ:BGNE) has acquired FDA approval for its drug Tevimbra within the therapy of superior or metastatic esophageal squamous ...
MacroGenics: Evaluating Buy Status After A 200% Surge On Prostate Cancer Prospects (MGNX)
Klaus Vedfelt/DigitalVision through Getty Photographs Introduction MacroGenics' (NASDAQ:MGNX) inventory is up 230% since my "Purchase" suggestion in September. Looking for ...
Leading the Charge in Next-Generation Cancer Therapies – TradersPro
Nkarta Inc (NKTS) is a biotechnology firm centered on the analysis, growth, and commercialization of pure killer (NK) cell ...
Ezra Raises Another $21M for Full Body MRIs Powered by AI That Makes Early Detection Possible for Cancer and 500 Other Types of Diseases
Early detection of most cancers considerably improves the survival price (80%), streamlines therapy choices, and finally reduces the price of ...
Medivir reports progress in liver cancer study By Investing.com
© Reuters. STOCKHOLM - Medivir AB (Nasdaq Stockholm: MVIR), a Swedish pharmaceutical firm, introduced important scientific developments for its most ...